2 completed, 2 recruiting, 1 terminated, 1 unknown. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 2, Recruiting 2, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Functional Gastrointestinal Disorders: new trials by email Literature Review of Functional Gastrointestinal Disorders trials Research Report on Functional Gastrointestinal Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC) Crofelemer Powder for Oral Solution, Matched Placebo Powder for Oral Solution - Short Bowel Syndrome, Malabsorption Syndromes | Phase 2 | Recruiting | Napo Therapeutics, S.p.A. | 18 | 2025-05-29 | 2026-06-09 |
| Exploring Novel Therapeutic Approaches for Disorders of Gut-Liver-Brain Interaction-H1/H2 Famotidine, Levocetirizine, Fuyuan Gasmin - Functional Gastrointestinal Disorders | Phase 2 | Recruiting | Buddhist Tzu Chi General Hospital | 45 | 2025-01-01 | 2026-10-05 |
| Exploring Treatments for Children's Abdominal Pain: Comparing Trimebutine and Probiotics Trimebutine, Lactobacillus rhamnosus, Placebo - Functional Abdominal Pain Syndrome, Functional Gastrointestinal Disorders | Phase 1 / Phase 2 | Unknown | Universidad de Colima | 82 | 2024-09-01 | 2024-08-16 |
| Phase 2a Study of IW-9179 to Treat Functional Dyspepsia IW-9179, Placebo - Dyspepsia, Functional Gastrointestinal Disorders | Phase 2 | Terminated | Ironwood Pharmaceuticals, Inc. | 10 | 2012-10-01 | 2014-03-19 |
| Study in Patients Suffering From Heartburn and Backward Flow of Stomach Liquid Into the Esophagus STW5 (Iberogast®, BAY98-7411), Placebo - Functional Gastrointestinal Disorders | Phase 2 | Completed | Bayer | 64 | 2009-06-18 | 2019-09-19 |
| An Effectiveness and Safety Study of Chinese Herbal Medicine for Functional Constipation MaZiRenWan (MZRW), Placebo - Functional Gastrointestinal Disorders, Constipation | Phase 2 | Completed | Hong Kong Baptist University | 120 | 2008-07-01 | 2016-06-24 |
Gastrointestinal Diseases (6) · Dyspepsia (2) · Constipation (1) · Malabsorption Syndromes (1) · Postoperative Complications (1) · Short Bowel Syndrome (1)
Digestive System Diseases (6) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (3) · Signs and Symptoms, Digestive (3) · Intestinal Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1)
Famotidine (1) · Solutions (1) · Trimebutine (1) · iberogast (1) · levocetirizine (1) · ma zi ren wan (1) · microcrystalline cellulose (1)
Bayer (1) · Buddhist Tzu Chi General Hospital (1) · Hong Kong Baptist University (1) · Ironwood Pharmaceuticals, Inc. (1) · Napo Therapeutics, S.p.A. (1) · Universidad de Colima (1)
Germany (2) · Belgium (1) · China (1) · Italy (1) · Mexico (1) · Netherlands (1) · Taiwan (1)
2008 (1)